AntiViral2025_EventsAir
Topics
Meeting category
Date(s)
3 Sep 2025 - 5 Sep 2025
Important dates
Abstract Submission Deadline
Friday, 30 May 2025 at 23:59 CEST
Early Fee Registration Deadline
Sunday, 2 February 2025 at 23:59 CET
Location
Amsterdam, Netherlands
Meeting type
Hybrid Workshop
Register Here
Submit your abstract

26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025

Register Here
General
About this Program

It is our pleasure to announce that the International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025 will take place as a hybrid workshop from 3-5 September 2025 in Amsterdam, The Netherlands. 

The International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs gathers leading experts to discuss all aspects of the optimal use of antiviral therapy including drug-drug interactions, pharmacokinetics of investigational and existing drugs, pharmacodynamics, drug dosing in underrepresented populations, post-marketing surveillance, and regulatory considerations.

What's New
  • The Abstract Submission Portal is open until 30 May 2025 at 23:59 CEST. 
     
  • Registration for the workshop is open. Registration waivers and discounts are available for specific categories. Please visit the "Registration" tab for more information.
     
  • The enduring materials of the previous edition of the workshop is here.

Program Chairs 2025
General Information 
COVID-19 Update
Responding to the changing COVID-19 situation, the International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024 will be held as a hybrid meeting allowing both in-person and virtual attendance. This workshop format is an optimal solution in light of the current circumstances.

We are available to answer any questions or concerns that you may have about your participation. For more information, please contact Jesper Niesen via Jesper.Niesen@amededu.com.
Who Should Attend?
- Clinical pharmacologists;

- Pharmacists;

- Clinicians/ researchers;

- Industry representatives;

- Regulatory scientists;

- Government representatives;

- Post-graduate students; and

- Others involved in the clinical pharmacology of antiviral therapy.
Meeting Objectives
This meeting aims to:

- Gather experts involved in clinical pharmacology from different disciplines in an interactive workshop setting;

- Provide a platform for presentation and discussion of the latest developments in the field;

- Share information on ongoing pharmacological studies; and

- Stimulate discussion and consensus on best practices.
Learning Objectives
After participating in this activity, participants will be able to:

- Outline new developments and the clinical pharmacology of antiviral therapies for HIV, COVID-19, Hepatitis, and other viruses;

- Reflect on new Drug Detection / Delivery Technologies; and

- Describe pharmacological considerations in key populations.
Practical Information 
Venue
The Venue for the International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025 will be confirmed shortly.
Travel
Travel is not included in the registration fee.
Accommodation
Accommodation is not included in the registration fee.
Badges
All participants are requested to wear the badge at all times during the program to ensure admission to the workshop.
Certificate of Attendance
A certificate of attendance will be sent to participants after they have successfully completed the program and post-workshop survey.
Language
The official language of the workshop is English.

Translation will not be provided.
Workshop Materials
Workshop materials can be obtained upon registration at the registration desk at the venue.
Disclaimer
This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop.
Liability and Insurance
By registering for the workshop participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.
Code of Conduct
All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.

Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.

Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Registration
Registration is Open!
Register Here
Early Fee Registration Deadline: Sunday, 2 February 2025 at 23:59 CET
Fees and Conditions

In-Person Registration

Regular Delegates 

Industry Delegates

Early Fee (payment before/on 2 February 2025)

€595

€895

Standard Fee (payment before/on 29 June 2025)

€745

€1,045

Late Fee (Payment from 30 June to 5 September 2025)

€845

€1,145


Virtual Registration

Regular Delegates 

Industry Delegates

Early Fee (payment before/on 2 February 2025)

€495

€795

Standard Fee (payment before/on 29 June 2025)

€645

€945

Late Fee (payment from 30 June to 5 September 2025)

€745

€1,045

Fee Waivers

Abstract Submitters who are eligible as:

Early-Career Investigators (ECI); OR
"Regular Delegates" from a Resource-Limited Setting (RLS)

50% discount on the Early Fee

Abstract Submitters who are eligible as "Regular delegates" from a High Income Countries

Early applicable fee

Early-Career Investigators (ECI) & "Regular Delegates" from a Resource-Limited Setting (RLS)

50% discount on the current applicable fee

Representatives of Endorsing Organizations 

25% discount on the current applicable fee

Representatives of Sponsoring Industry

Please contact the workshop secretariat

Financial Concerns

If you have financial concerns, please contact the meeting secretariat

*Countries included in the low-income and middle-income economies list of the World Bank Classification

Important

  • We strongly advise that you register early to ensure your registration. Registration will close when the capacity of the venue is reached.

  • Submission of your online registration does not guarantee that your registration has been accepted. Your registration is final when full prepayment has been received and a confirmation of your registration has been sent.

Registration Fee Includes
For onsite attendees:

- Access to all scientific sessions, including poster area

- Refreshments during the coffee breaks

- Buffet lunch on meeting days

For virtual attendees only:

- Access to all scientific sessions

- Digital workshop pack, including the program

IMPORTANT:

- No day rate is available

- Payment can only be made by credit card.

- Virology Education reserves the right to cancel improper registrations. Claims for a refund will not be honored.
Group Registration
For registration of groups larger than 5 participants, please use the Group Registration Portal.
Early-Career Investigators / Regular Delegates from Resource-limited Settings (RLS)
We are pleased to offer 50% discount on the Early Fee for early-career investigators and academia from low-income and lower-middle-income countries with an accepted abstract and a 50% discount on the regular fee without an accepted abstract.

IMPORTANT: The discount is offered to the presenting author only.

To be eligible as an early-career investigator, one should either be a current Master/PhD student or have obtained an MD/PharmD/PhD degree in the last five years. An application form needs to be completed by a supervisor and received by the Virology Education secretariat at least two weeks prior to the start of the workshop. Virology Education will contact the early-career investigator with instructions regarding the registration procedure.
Payment
By credit card only: online or by written authorization.

Please contact the workshop secretariat via Jesper.Niesen@amededu.com if you need to make alternative arrangements.
Cancellation Policy
In case of cancellation, the following refunds are applicable:

- Cancellation before/on 3 August 2025: 50% refund (minus an administration fee of €40)

- Cancellation after 3 August 2025: Unfortunately, no refund will be given

If you are unable to attend the workshop, a substitute delegate is always welcome at no extra charge, provided that a letter of authorization from the original participant has been received and the workshop secretariat has been notified of the name of the substitute delegate before 17 August 2025. A statement (email/letter) of cancellation must be sent to Virology Education.
Liability and Insurance
By registering for the workshop, participants agree that the organizers do not accept responsibility for medical, travel, or personal insurance. Participants are advised to take out their own insurance policies.
Media Registration
In order to register as a media participant for the workshop, the workshop secretariat needs to receive:

1. Proof of accreditation
2. Valid identification (e.g. passport)
3. A letter from your assignment giver stating the details of your assignment (e.g. editor)
4. At least 3 previous written assignments in recognized outlets on HIV. If you are a freelance journalist, the assignments can be from different (recognizable) news outlets. Links to online publications are accepted
5. The website of the publication(s)/blog(s) that will be featuring your story on this workshop

A complimentary or reduced registration fee may apply for accredited media participants depending on availability. Preference will be given to credible print and online news sources. Please contact the workshop secretariat for registration conditions.

We would like to receive a copy of your workshop report/ article once it is finalized.
All credentials will be verified by the Organizing Committee of the Workshop. Media representatives are kindly requested to register by sending the above-mentioned information to info@amededu.com.

Important: Media is restricted to the written press. Recording on film or photo is not allowed. Virology Education will request a copy of the written piece once it is finalized. Media representatives must also agree to abide by the 2025 embargo policy.
Disclaimer
This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The organizing secretariat of this workshop, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this workshop. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop. In case of cancellation of the meeting due to unforeseen circumstances, Virology Education cannot be held responsible for expenses made for travel, accommodation, visa applications, etc.
Downloads:
Downloads:
Program

The program of the International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025 is currently under development.

Abstracts
Abstract Submission Deadline: Friday, 30 May 2025 at 23:59 CEST
Submit Here
Image
Antiviral PK
Abstracts
  • International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025 accepts new original data as well as encored abstracts. All abstracts must contain up-to-date information at the time of the workshop. 
  • 50% discount on the early fee will be offered for early-career professionals with an accepted abstract. A 50% discount on the regular registration fee is offered to early-career professionals without an accepted abstract. The requirements for the application are specified under the "Registration" tab.

  • Abstract submitters are strongly encouraged to use person-first language in their abstracts. View the video tutorial and guidelines here

  • Abstract presenters are expected to attend the workshop in-person to present their abstract.

    Please contact the workshop secretariat if this is not possible.

Categories for Abstract Submission
For purposes of review and programming, abstracts are divided into topical categories. The selection of the most appropriate category is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category. Click here for an overview of the categories.

Abstract Categories:

- Cellular and Tissue Pharmacokinetics
- Drug-Drug Interactions
- Novel Drugs and Formulations
- Pharmacogenetics
- Pharmacokinetics during Pregnancy and Other Key Populations
- PK/PD of Drug Efficacy and Toxicity (including TDM)
General Guidelines
Abstracts should contain the following four components:

- Background: A concise statement of the issue under investigation or a hypothesis;

- Material and Methods: The experimental methods used (including the statistical analyses employed);

- Results: Specific findings (promises such as "to be completed" or "to be presented" are not acceptable);

- Conclusions: A summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).

Please note that abstracts cannot be accepted if tables or graphs are included. The maximum word count for the abstract body is 500 words.

Abstracts are considered official communications to the workshop and will be treated confidentially. Submitters of accepted abstracts agree to attend the meeting and present their abstract as scheduled.

We encourage you to use person-first language in your abstract(s). View our guidelines here: https://academicmedicaleducation.com/person-first-language
Abstract Submission
Authors can submit their abstracts electronically until Friday, 30 May 2025 at 23:59 CEST. You will be redirected to the submission website. Please follow the step-by-step directions to upload the abstract. To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format.
Committees
Program Chairs 2025
Organizing Committee
The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.
Scientific Program Coordinator
Scientific Committee
  • Vikram Arya, PhD, FCP - Food and Drug Administration, United States
     
  • Kristina Brooks, PharmD - University of Colorado Anschutz Medical Campus, United States
     
  • Andrea Calcagno, MD, DTM&H - University of Turin, Italy
     
  • Su-Young Choi, PharmD, PhD - Food and Drug Administration, United States
     
  • Angela Colbers, PhD - Radboud University Medical Center, the Netherlands
     
  • Paolo Denti, PhD - University of Cape Town, South Africa
     
  • Tanuja N. Gengiah, B.Pharm, MClinPharm, Ms(Epi), PhD - Centre for the AIDS Programme of Research (CAPRISA) & University of KwaZulu-Natal, South Africa
     
  • Mohammed Lamorde, MD - Infectious Diseases Institute, Uganda
     
  • Minh Patrick Lê, PhD - Hôpital Bichat-Claude Bernard, France
     
  • Lawrence Lee, MBBS, PhD - National University of Singapore, Singapore
     
  • Catia Marzolini, PharmD, PhD - University Hospital Basel, Switzerland & University of Liverpool, United Kingdom
     
  • Steve Taylor, MRCP, PhD - Birmingham Heartlands Hospital, United Kingdom
     
  • Catriona Waitt, MBChB, PhD - University of Liverpool, United Kingdom 
     
  • Julie Dumond, Pharm.D., M.S. - UNC Eshelman School of Pharmacy,United States
The members of Scientific Committee are hand-picked by the Organizing Committee and the workshop secretariat based on their significant contributions and commitment to the field. They assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.
Academic Advisory Board
  • David Back, PhD - University of Liverpool, United Kingdom
     
  • Terrence Blaschke, MD - Stanford University School of Medicine, United States
     
  • Marta Boffito, MD, PhD, FRCP - Chelsea and Westminster Hospital London, United Kingdom
     
  • David Burger, MD, PhD - Radboud University Medical Center, the Netherlands
     
  • Giovanni Di Perri, MD, PhD - University of Torino, Italy
     
  • Courtney Fletcher, PharmD - University of Nebraska Medical Center, United States
     
  • Charles Flexner, MD - Johns Hopkins University, United States
     
  • Angela Kashuba, PharmD - University of North Carolina at Chapel Hill, United States
     
  • Jürgen Rockstroh, MD - University of Bonn, Germany
     
  • Jonathan Schapiro, MD - National Hemophilia Center, Sheba Medical Center, Israel
The members of the Academic Advisory Board (AAB) are former members of the OC and remain active the in planning of the program for the next year. Members of the current OC are selected from this group. 
Industry Liaison Board
  • Wei Liu - AbbVie
     
  • Thomas Kakuda - Janssen, Pharmaceutical Companies of Johnson and Johnson
     
  • Xiao-Jian Zhou - ​​​​​​Atea Pharmaceuticals
     
  • Simon Portsmouth - Shionogi
The Industry Liaison Board, consisting of leading medical scientists of the pharmaceutical industry, is asked to give input and suggestions that help the Organizing Committee in planning the workshop and providing support on topics of interest and innovative suggestions to optimize audience participation. The Industry Liaison Board assists the Organizing Committee by suggesting the most current and critical topics to bring the audience up-to-date on the most current research in the pharmaceutical industry in related disciplines.
Support
Support Our Initiative

Financial backing helps us deliver an impactful meeting experience to the benefit of healthcare professionals and researchers interested in the International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025.
 
This collaboration plays a vital role in both the organizational as well as scientific success of the program.

To show your commitment to the cause, get in touch with us for a tailored
support package by contacting Daria Bohdanova at Daria.Bohdanova@amededu.com or call +31 30 230 7140.
 
Benefits of Support
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.

  • Symposium opportunities
  • Non-commercial interviews with company representatives
  • Verbal acknowledgement during the program 
  • Discounted and complimentary registrations for your representatives
  • Company acknowledgement on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
  • Company acknowledgement on printed meeting materials including but not limited to banners and the program book
  • Digital and printed advertising opportunities 
  • Social media shout-outs
  • Logo on the bag 

 
*Subject to the support level.

Previous Editions
Previous Editions
Language
Afbeelding
Jesper
Caption
Hi! I’m Jesper
Label / Name
How can I help you?
Go to Contact form webform